Therapeutics: Integrin avβ3 (CD51/CD61)

Cancer

INDICATION: Cancer

In vitro and mouse studies identified a protein inhibitor of the integrin CD51/CD61 that could help treat cancer. In silico analysis of the

Read the full 249 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE